[Is there any likelihood of antagonism when antibiotic combinations are used in clinical practice?].
D002353:Carrier State; D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use*; D004357:Drug Synergism; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D010406:Penicillins / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013752:Tetracycline / Q000627:therapeutic use*; D014069:Tonsillitis / Q000188:drug therapy*
D010406:Penicillins; D004917:Erythromycin; D002701:Chloramphenicol; D013752:Tetracycline
Ist in der Klinik mit einem Antagonismus bei Antibiotika-Kombinationen zu rechnen?